Want to see AHCO full AI Analyst Report?
AHCO Stock Chart & Stats
$5.48
$0.29(2.77%)
At close: 4:00 PM EDT
$5.48
$0.29(2.77%)
Day’s Range― - ―
52-Week Range$5.21 - $13.43
Previous Close$10.7
Volume821.52K
Average Volume (3M)2.31M
Market Cap
$822.16M
Enterprise Value$3.45B
Total Cash (Recent Filing)$43.29M
Total Debt (Recent Filing)$2.07B
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Nov 03, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.68
Shares Outstanding136,344,200
10 Day Avg. Volume2,027,952
30 Day Avg. Volume2,311,165
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.89
Price to Sales (P/S)0.41
P/FCF Ratio6.14
Enterprise Value/Market Cap4.19
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit11.05
Enterprise Value/Ebitda11.86
Forecast
1Y Price Target
$9.40Price Target Upside71.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.2
Revenue Forecast (FY)$2.88B
Bulls Say, Bears Say
Bulls Say
Organic Revenue GrowthStrong organic growth indicates continued demand for AdaptHealth’s home-based therapies and supplies. Sustained expansion can improve operating leverage, deepen provider and payer relationships, and support recurring patient revenue over the next several quarters.
Core Segment MomentumGrowth across the core Sleep and Respiratory businesses supports a durable market position rather than reliance on one product category. These essential home therapies can broaden patient relationships, reinforce referral channels, and provide a stronger base for future profitability.
Portfolio SimplificationDivesting Diabetes Health should concentrate management attention and capital on AdaptHealth’s stated core growth areas. Proceeds may improve financial flexibility for debt reduction and reinvestment, while a simpler portfolio could support better margins and execution.
Bears Say
Severe Margin And Profitability PressureThe sharp gross-margin contraction and return to a sizable net loss weaken the earnings base supporting the business. Persistent profitability pressure can restrict reinvestment, reduce resilience to reimbursement or cost changes, and make growth less valuable if margins do not recover.
Elevated Leverage And Weaker Cash ConversionElevated leverage combined with recent negative quarterly free cash flow reduces financial flexibility while the company funds growth and operational remediation. This can constrain capital allocation, increase dependence on successful cash generation, and prolong the path toward balance-sheet improvement.
Regulatory Constraint On New FootprintThe moratorium delays revenue opportunities from newly established locations and prevents those sites from absorbing fixed costs through fee-for-service volume. That restriction may prolong underutilization, slow expected economies of scale, and complicate the contract’s path to profitability.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $5.21 and its highest was $13.43 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $822.16M.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 03, 2026 which is in 5 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 04, 2026. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.169 by -$0.009.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is -0.05.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 136,344,200 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.16 in its last earnings report, missing expectations of $0.169. Following the earnings report the stock price went down -38.042%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.40 (71.53% Upside)
$9.40 (71.53% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 69.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $394.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.32%
12-Months-Change
Fundamentals
Return on Equity
-15.16%
Trailing 12-Months
Asset Growth
-0.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AdaptHealth
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: underlying top-line growth and strong segment performance (double-digit organic growth, expanding capitated revenue, digital adoption, strategic portfolio simplification and actions to reduce debt) are meaningful positives. However, material near-term headwinds — notably operational inefficiencies and elevated costs on a large West Coast capitated contract, an unexpected supplier price increase ($30M H2 impact), a significant reduction in full-year adjusted EBITDA guidance, a Q2 negative free cash flow driven by elevated CapEx, and a $144.2M goodwill impairment — temper the outlook. Management outlined concrete remediation steps (workflow fixes, technology/digital adoption, restructuring savings, debt paydown plans and expected elimination of stranded overhead) and expects sequential improvement toward run-rate profitability, but the magnitude of the near-term earnings and cash-flow impacts means the positives and negatives are largely in balance for the near term.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$9.40
▲(71.53% Upside)
Technical Analysis
Ownership Overview
15.24% Insiders
23.02% Mutual Funds
0.61% Other Institutional Investors
37.19% Public Companies and
Individual Investors